https://www.selleckchem.com/pr....oducts/gsk591-epz015
6%, 93.1%, 92%, 87.4%, and 82.8%in BCAVF patients, and 96.7%, 93.3%, 90%, 86.7%, and 80%in BVTAVF patients, respectively. The percentages of secondary patency rates at 6, 12, and 24months were 100%, 93.3%, and 86.7% in BCAVF patients, and 100%, 100% and 87.7% in BVTAVF patients, respectively. Fistula thrombosis was seen as the most common complication. The early complication was bleeding/hematoma. As late complications, we encountered steal syndrome, ischemic pain in the relevant extremity, pseudoaneurysm, and high-o
Like
Comment
Share
